AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

14,076.00p
   
  • Change Today:
      38.00p
  • 52 Week High: 14,258.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.91m
  • Volume: 337,285
  • Market Cap: £218,306m
  • RiskGrade: 123
  • Beta: 1.23

Latest Deals

Traded Action Notifier PriceAmountValue
18-Dec-25 Sell Nazneen Rahman 13,496.00p 297 £40,083.12

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
18-Dec-25 Sell Nazneen Rahman 13,496.00p 297 £40,083.12

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 746,354 £105,056,789
Aradhana Sarin 93,804 £13,203,851
Marcus Wallenberg 60,028 £8,449,541
Philip A J Broadley 19,495 £2,744,116
Michel Demare 10,000 £1,407,600
Tony Mok 3,500 £492,660
Sheri McCoy 1,736 £244,359
Karen Knudsen 1,405 £197,768
Diana Layfield 1,400 £197,064
Euan Ashley 1,150 £161,874
Nazneen Rahman 720 £101,347
Anna Manz 487 £68,550

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £14,200,598,078
Oddo Meriten Asset Management SA 100,885,181 £14,200,598,078
The Capital Group Companies, Inc. 77,125,348 £10,856,163,984
Wellington Management Company LLP 65,118,411 £9,166,067,532
Investor AB 51,587,810 £7,261,500,136

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 14,076.00p
Change Today 38.00p
% Change 0.27 %
52 Week High 14,258.00p
52 Week Low 9,667.00p
Volume 337,285
Shares Issued 1,550.91m
Market Cap £218,306m
Beta 1.23
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 07-Jan-2026

Time Volume / Share Price
13:30 0 @ 14,074.00p
13:30 0 @ 14,074.00p
13:30 19 @ 14,076.00p
13:30 70 @ 14,076.00p
13:30 31 @ 14,076.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page